SCHEDULE 13D/AAccepted Sep 3, 5:31 PM ET
Apogee Therapeutics, Inc. SCHEDULE 13D/A
Accepted (ET)
5:31 PM
Sep 3, 2026
Filed
Sep 3, 2026
Documents
1
Size
14.4 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.